Doctor profile · Federal record
Dr. BRIAN ABITTAN, M.D.
Dermatology Physician (CMS: DERMATOLOGY) · Student in an Organized Health Care Education/Training Program · NEW YORK, NY
- NPI 1902284482
- Accepts Medicare
- 11 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
234 E 85TH ST FL 5
NEW YORK, NY 100283001
(212) 241-6585 - Mailing address
-
450 CLARKSON AVE
BROOKLYN, NY 112032098
Credentials & registration
- NPI registered
- May 2015 — 11 yrs on file
- Profile last updated
- September 2, 2021
- Year of graduation
- 2015 — 11 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- New York #285104
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1902284482. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
841
Distinct HCPCS
10
Medicare allowed
$63,088
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 244 | 130 | $95 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 144 | 54 | $7 | |
17000 |
Destruction of precancer skin growth, 1 growth | 103 | 72 | $55 | |
11102 |
Biopsy of related skin growth, first growth | 94 | 81 | $105 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 49 | 23 | $1 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 43 | 40 | $136 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 37 | 37 | $119 | |
11103 |
Biopsy of related skin growth, each additional growth | 32 | 25 | $53 | |
11901 |
Injection into skin growth, more than 7 growths | 28 | 13 | $72 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 24 | 20 | $179 |
In context: peer comparison
Among 139 peers in this city , average services per provider: 182. This provider delivers 4.6× the peer median.Open Payments
Industry payments received
All-time total
$42,028
Transactions
179
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lilly USA, LLC | 78 | $40,121.51 | |
| Dermavant Sciences, Inc. | 18 | $487.68 | |
| E.R. Squibb & Sons, L.L.C. | 25 | $386.44 | |
| ABBVIE INC. | 29 | $377.58 | |
| Arcutis Biotherapeutics, Inc. | 15 | $182.34 | |
| PFIZER INC. | 5 | $101.92 | |
| Janssen Biotech, Inc. | 1 | $99.99 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $85.47 | |
| LEO Pharma Inc. | 2 | $56.13 | |
| GENZYME CORPORATION | 2 | $50.13 | |
| REVANCE THERAPEUTICS, INC. | 1 | $36.88 | |
| UCB, Inc. | 1 | $22.35 | |
| Biofrontera Inc. | 1 | $19.76 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
712
Patients
437
Total drug cost
$23,092
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Minoxidil | Generic | 99 | 38 | $1,612 |
| Clobetasol Propionate | Generic | 79 | 46 | $4,169 |
| Ketoconazole | Generic | 75 | 51 | $2,058 |
| Ammonium Lactate | Generic | 69 | 38 | $1,767 |
| Triamcinolone Acetonide | Generic | 58 | 50 | $2,424 |
| Mupirocin | Generic | 53 | 47 | $475 |
| Clindamycin Phosphate | Generic | 48 | 25 | $2,699 |
| Finasteride | Generic | 44 | 13 | $925 |
| Mometasone Furoate | Generic | 35 | 33 | $1,046 |
| Fluocinonide | Generic | 31 | 22 | $1,392 |